In this episode Jonathan Rosenfeld chats with Martin D. Gould (https://rblaw.net/attorneys/martin-d-gould/) an Attorney at Romanucci & Blandin, LLC (https://rblaw.net/). (https://lanzonemorgan.com/) Here, they discuss: Zantac Lawsuits Update (https://www.rosenfeldinjurylawyers.com/zantac-cancer-lawsuits.html)   Read the Transcript Download the PDF Jonathan Rosenfeld : Hi, I am Jonathan Rosenfeld and I am an attorney, and I am with my good friend and colleague Marty Gould today. We are here to talk about probably one of the largest and most prolific drug recalls in the United States ever, certainly in recent history, and that involves the popular heartburn medication Zantac. Jonathan Rosenfeld : Marty is very active with the Zantac litigation, and he is here today to discuss the status of the litigation who qualifies for this and to sort of give us some insight as to how these cases may play out. Jonathan Rosenfeld : Marty, first off, thank you for joining me today. I appreciate it, and could you just briefly introduce yourself, and let us know a little bit about the background and just what Zantac is and bring us up to date with the current status of the recall on Zantac? Marty Gould: John, thanks for the introduction. I'm of counsel with Rosenfeld Injury Lawyers. Our team represents hundreds and hundreds of individuals that have cancer that we believe was caused by a Zantac consumption or generic. Zantac was a very popular heartburn and acid reflux medication. Marty Gould: Millions and millions of people have used Zantac for those purposes, and recent studies have shown that there's a connection between an ingredient in Zantac, ranitidine, and cancer. It's the chemical structure of the Zantac tablet that once it's consumed, and once it's mixed with water in your body, it causes what's called NDMA, a very toxic substance that is linked to cancer. Marty Gould: For that reason, people that have been taking Zantac, many of these people for years and years on a frequent basis, are now getting cancer. Typically, it's a stomach cancer, bladder cancer, stomach cancer, but also the blood-based cancers such as liver cancer. Right now, there's a litigation that's being handled, a multi-district litigation, where all the Zantac cases are being filed in the Southern District of Florida. Marty Gould: Anyone who has a case, they're filing their claims there, and the lawyers are litigating those cases now. We're still in the earlier stages, and there's trials that are expected to start going in probably 2022. Jonathan Rosenfeld : Now, you mentioned that these cases are filed in what's called a multi-district litigation or MDL. I want to talk with you about the differences between an MDL that some people may not be familiar with and a traditional lawsuit. First off, I guess, as a starting point, I guess, what is an MDL case? Marty Gould: Sure. Multi-district litigation is essentially a type of case where all the cases may be a little bit different, so if you've been taking Zantac for one year, several times a week, and somebody else has been taking Zantac for 10 years on a daily basis, you may have a different type of case because your exposure was different. If you have a family history of cancer, that may be a relevant facts. Marty Gould: Everyone's case is a little bit different. Everyone's injuries are a little different. Some people tragically are filing a case on behalf of a loved one who's deceased, who has died because of cancer linked to Zantac. Others may just have an early diagnosis,